
What does it take to turn longevity research into medicine people can rely on?
Prof. Andrea B. Maier joins Pierre Jacob and Meronn Jacob on Transcribed to discuss precision geromedicine, the work of preserving health and function as we age, and the standards needed to bring this approach into wider clinical practice.
Andrea explains how she approaches a first clinic visit, why a person's goals and daily life matter alongside biological measurements, and why making care accessible starts with defining what good care looks like. She also discusses the evidence behind DNA methylation clocks, promises to cure all disease within a few years, and the difference between improving function and claiming to reverse aging.
In this conversation:
◼️ What Andrea means by precision geromedicine
◼️ What happens when someone visits her clinic
◼️ Clinical standards and making longevity medicine more accessible
◼️ DNA methylation clocks and the evidence needed for clinical use
◼️ AI, longevity promises, and realistic expectations
◼️ Why she co-founded the Healthy Longevity Medicine Society
◼️ Training the next generation at NUS
◼️ Function, aging, and finding the right mentor
RESOURCES FROM THE CONVERSATION
Featured programme: NUS Academy for Healthy Longevity
Andrea's team describes the programme discussed as the Master of Science in Precision Geromedicine / Geroscience, with intakes offered every six months. For current programme names, availability, and application details, please consult the Academy's page:
https://longevityacademy.sg/education/master-graduate-certificate
The page currently lists the Graduate Certificate in Healthy Longevity Medicine and progression towards a future Master in Healthy Longevity Medicine. Applications for the 2026 intake are closed; follow the page for updated intake information.
Professional membership: Healthy Longevity Medicine Society (HLMS)
Learn about membership and the Society's work towards standardizing global clinical practice in healthy longevity medicine:
https://hlms.co/
Reference paper supplied by Andrea's team:
“Guidelines and recommendations on the clinical utility of DNA methylation clocks in precision geromedicine” (Maier et al.). Status supplied by the team: submitted / under review. A publication link is not yet available in the supplied reference.
Transcribed Podcast: in-person interviews with scientists, founders, and industry experts shaping the future of biotech and pharma.
New episodes every Tuesday at 16:00 Berlin time.
🎙️ Watch all episodes: https://www.youtube.com/@TranscribedPod
📥 Free Biotech Starter Pack: https://transcribedpod.com
📸 Instagram: @transcribedpod
📧 [email protected]
🎵 Jingle composed by Tembeh: https://open.spotify.com/artist/4s9JmadJjVdYQ6YxYtJgja
⚠️ Disclaimer: For information and education only. Not medical, financial, investment, tax or legal advice. Guests share their own experiences and opinions, not necessarily those of Transcribed or its hosts. Nothing here is a recommendation to start, stop or change any treatment, supplement or investment; consult a qualified professional about your own situation. Mentions of companies or products are not endorsements, and Transcribed accepts no liability for decisions based on this content.
00:00 Introducing Prof. Andrea B. Maier
00:32 Aging, health, and preserving function
01:38 What is precision geromedicine?
03:37 Inside Andrea's clinic
06:33 Making longevity medicine more accessible
08:33 Research, DNA methylation clocks, and clinical evidence
10:27 Lessons from senescence research
11:19 AI timelines and longevity promises
13:36 Building the Healthy Longevity Medicine Society
15:27 Education at the NUS Academy for Healthy Longevity
16:06 Can aging be reversed?
17:48 Advice for people entering the field
19:29 Closing conversation
Weitere Episoden von „Transcribed“



Verpasse keine Episode von “Transcribed” und abonniere ihn in der kostenlosen GetPodcast App.








